Latent Epstein–Barr virus infection status and prognosis in patients with newly diagnosed Hodgkin lymphoma in Southeast China: a single-center retrospective study

References

• Townsend W, Linch D. Hodgkin’s lymphoma in adults. J Lancet. 2012;380:836–847. doi:https://doi.org/10.1016/S0140-6736(12)60035-X.
   Google Scholar
• Glaser SL, Hsu JL. Hodgkin’s disease in Asians: incidence patterns and risk factors in population-based data. J Leuk Res. 2002;26:261–269. doi:https://doi.org/10.1016/s0145-2126(01)00126-6.
   PubMed Web of Science ®Google Scholar
• Xiao-qiu LI, Gan-di LI, Zi-fen GAO, et al. Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of 10 002 cases. J Diagn Concepts Pract. 2012;11:111–115. http://kns.cnki.net/KCMS/detail/detail.aspx?FileName=ZDLS201202007&DbName=CJFQ2012%25%5C 2020-10-21 21:40:00.
   Google Scholar
• Flavell KJ, Linford JA, Flavell JR, et al. Detection of Epstein-Barr virus in archival Hodgkin’s disease specimens. Mol Pathol. 2000;53:162. doi:https://doi.org/10.1136/mp.53.3.162.
   PubMedGoogle Scholar
• Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol. 1987;129:86–91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2821817&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Murray P, Bell A. Contribution of the Epstein-Barr virus to the pathogenesis of Hodgkin lymphoma. Curr Top Microbiol Immunol. 2015;390:287–313. doi:https://doi.org/10.1007/978-3-319-22822-8_12.
   PubMed Web of Science ®Google Scholar
• Tang LL, Chen WQ, Xue WQ, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374:22–30. doi:https://doi.org/10.1016/j.canlet.2016.01.040.
   PubMed Web of Science ®Google Scholar
• Wei KR, Zheng RS, Zhang SW, et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33:381–387. doi:https://doi.org/10.5732/cjc.014.10086.
   PubMed Web of Science ®Google Scholar
• Jarrett RF. Viruses and Hodgkin’s lymphoma. J Ann Oncol. 2002;13(Suppl 1):23–29. doi:https://doi.org/10.1093/annonc/13.s1.23.
   PubMed Web of Science ®Google Scholar
• Armstrong AA, Lennard A, Alexander FE, et al. Prognostic significance of Epstein-Barr virus association in Hodgkin’s disease. J Eur J Cancer. 1994;30A:1045–1046. doi:https://doi.org/10.1016/0959-8049(94)90157-0.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068. doi:https://doi.org/10.1200/jco.2013.54.8800.
   PubMed Web of Science ®Google Scholar
• Rickinson A. Epstein-Barr virus. Virus Res. 2002;82:109–113. doi:https://doi.org/10.1016/s0168-1702(01)00436-1.
   PubMed Web of Science ®Google Scholar
• Farrell PJ. Epstein-Barr virus and cancer. Annu Rev Pathol. 2019;14:29–53. doi:https://doi.org/10.1146/annurev-pathmechdis-012418-013023.
   PubMed Web of Science ®Google Scholar
• Yi M, Cai J, Li J, et al. Rediscovery of NF-kappaB signaling in nasopharyngeal carcinoma: How genetic defects of NF-kappaB pathway interplay with EBV in driving oncogenesis? J Cell Physiol. 2018;233:5537–5549. doi:https://doi.org/10.1002/jcp.26410.
   PubMed Web of Science ®Google Scholar
• Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis. 2003;3:131–140. doi:https://doi.org/10.1016/s1473-3099(03)00543-7.
   PubMed Web of Science ®Google Scholar
• Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108–5121. doi:https://doi.org/10.1038/sj.onc.1206556.
   PubMed Web of Science ®Google Scholar
• Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–429. doi:https://doi.org/10.1016/s1044579 ( 02000858.
   PubMed Web of Science ®Google Scholar
• Condon LM, Cederberg LE, Rabinovitch MD, et al. Age-specific prevalence of Epstein-Barr virus infection among minnesota children: effects of race/ethnicity and family environment. Clin Infect Dis. 2014;59:501–508. doi:https://doi.org/10.1093/cid/ciu342.
   PubMed Web of Science ®Google Scholar
• Dowd JB, Palermo T, Brite J, et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6–19, 2003–2010. PLoS One. 2013;8:e64921. doi:https://doi.org/10.1371/journal.pone.0064921.
   PubMed Web of Science ®Google Scholar
• Ferres M, Prado P, Ovalle J, et al. [Seroprevalence of Epstein Barr virus infection in a healthy population of Santiago de Chile]. Rev Med Chil. 1995;123:1447–1452. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8733260&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Gares V, Panico L, Castagne R, et al. The role of the early social environment on Epstein Barr virus infection: a prospective observational design using the Millennium Cohort study. Epidemiol Infect. 2017;145:3405–3412. doi:https://doi.org/10.1017/S0950268817002515.
   PubMed Web of Science ®Google Scholar
• Chen CY, Huang KY, Shen JH, et al. A large-scale seroprevalence of Epstein-Barr virus in Taiwan. PLoS One. 2015;10:e0115836. doi:https://doi.org/10.1371/journal.pone.0115836.
   PubMed Web of Science ®Google Scholar
• Gerber P, Lucas S, Nonoyama M, et al. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet. 1972;2:988–989. doi:https://doi.org/10.1016/s0140-6736(72)92402-6.
   PubMed Web of Science ®Google Scholar
• Miller G, Niederman JC, Andrews LL. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med. 1973;288:229–232. doi:https://doi.org/10.1056/NEJM197302012880503.
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328–1337. doi:https://doi.org/10.1056/NEJMra032015.
   PubMed Web of Science ®Google Scholar
• Paschos K, Smith P, Anderton E, et al. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 2009;5:e1000492. doi:https://doi.org/10.1371/journal.ppat.1000492.
   PubMed Web of Science ®Google Scholar
• Ping LY, Ding N, Shi YF, et al. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin’s lymphoma after EBV infection]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22:78–84. doi:https://doi.org/10.7534/j.issn.1009-2137.2014.01.017.
   PubMedGoogle Scholar
• Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372. doi:https://doi.org/10.1098/rstb.2016.0271.
   Google Scholar
• Carbone A, Gloghini A, Caruso A, et al. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. Int J Cancer. 2017;140:1233–1245. doi:https://doi.org/10.1002/ijc.30473.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim Y, Choi JW, et al. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin’s lymphoma: a meta-analysis. Arch Med Res. 2014;45:417–431. doi:https://doi.org/10.1016/j.arcmed.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Asano N, Oshiro A, Matsuo K, et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin’s lymphoma: a clinicopathologic study. J Clin Oncol. 2006;24:4626–4633. doi:https://doi.org/10.1200/jco.2006.06.5342.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Clarke CA, Chang ET, et al. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus. Cancer Causes Control. 2014;25:709–725. doi:https://doi.org/10.1007/s10552-014-0374-6.
   PubMed Web of Science ®Google Scholar
• Ghesquieres H, Maurer MJ, Casasnovas O, et al. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts. Cytokine. 2013;64:523–531. doi:https://doi.org/10.1016/j.cyto.2013.08.002.
   PubMed Web of Science ®Google Scholar
• FU Q, JI H, ZHANG T, et al. Association between classical Hodgkin’s lympohoma and Epstein-Barr virus infection in Northern Chinese Han population. Chin J Clin Oncol. 2014;41:629–633. http://kns.cnki.net/KCMS/detail/detail.aspx?FileName=ZGZL201410005&DbName=CJFQ2014%25%5C 2020-10-21 21:43:00.
   Google Scholar
• Zeng W, Zhou M, Lin H. [The significance of detecting Epstein-Barr virus BNLF1 fragment and its expression in Hodgkin’s disease in the Guangdong area]. Zhonghua Bing Li Xue Za Zhi. 1997;26:27–30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10072846&query_hl=1.
   PubMedGoogle Scholar
• Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood. 2005;106:2444–2451. doi:https://doi.org/10.1182/blood-2004-09-3759.
   PubMed Web of Science ®Google Scholar
• Zhou XG, Sandvej K, Li PJ, et al. Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer. 2001;92:1621–1631. https://doi.org/https://doi.org/10.1002/1097-0142(20010915)92:6<1621::aid-cncr1488>3.0.co;2-p.
   PubMed Web of Science ®Google Scholar
• Kang S, Qin Y, He X, et al. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin’s lymphoma]. Zhonghua Yi Xue Za Zhi. 2015;95:2594–2598. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26711606&query_hl=1.
   PubMedGoogle Scholar
• Glaser SL, Gulley ML, Clarke CA, et al. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer. 2008;123:1499–1507. doi:https://doi.org/10.1002/ijc.23741.
   PubMed Web of Science ®Google Scholar
• Herling M, Rassidakis GZ, Medeiros LJ, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res. 2003;9:2114–2120. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12796376&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agent Cancer. 2014;9:38. doi:https://doi.org/10.1186/1750-9378-9-38.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet. 2012;380:2055–2058. doi:https://doi.org/10.1016/s0140-6736(12)62134-5.
   PubMed Web of Science ®Google Scholar
• Claviez A, Tiemann M, Luders H, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin’s lymphoma. J Clin Oncol. 2005;23:4048–4056. doi:https://doi.org/10.1200/jco.2005.01.701.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Liang B, Lu Y, et al. [Infection status and prognosis analysis of Epstein-Barr virus in patients with newly diagnosed Hodgkin’s lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24:1410–1415. doi:https://doi.org/10.7534/j.issn.1009-2137.2016.05.023.
   PubMedGoogle Scholar
• Keegan TH, Glaser SL, Clarke CA, et al. Epstein-Barr virus as a marker of survival after Hodgkin’s lymphoma: a population-based study. J Clin Oncol. 2005;23:7604–7613. doi:https://doi.org/10.1200/jco.2005.02.6310.
   PubMed Web of Science ®Google Scholar
• Herling M, Rassidakis GZ, Vassilakopoulos TP, et al. Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma. Blood. 2006;107:1240. author reply 1241. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16434497&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Morente MM, Piris MA, Abraira V, et al. Adverse clinical outcome in Hodgkin’s disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. J Blood. 1997;90:2429–2436. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9310494&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Montalban C, Abraira V, Morente M, et al. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin’s disease treated with chemotherapy. Leuk Lymphoma. 2000;39:563–572. doi:https://doi.org/10.3109/10428190009113386.
   PubMed Web of Science ®Google Scholar
• Engel M, Essop MF, Close P, et al. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin’s lymphoma: study of 47 South African cases. J Clin Pathol. 2000;53:182–186. doi:https://doi.org/10.1136/jcp.53.3.182.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin’s disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol. 2000;11:91–96. doi:https://doi.org/10.1023/a:1008337100424.
   PubMed Web of Science ®Google Scholar
• Vassallo J, Metze K, Traina F, et al. Expression of Epstein-Barr virus in classical Hodgkin’s lymphomas in Brazilian adult patients. Haematologica. 2001;86:1227–1228. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11694413&query_hl=1.
   PubMed Web of Science ®Google Scholar
• Diepstra A, van Imhoff GW, Schaapveld M, et al. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin’s lymphoma predicts adverse outcome in older adult patients. J Clin Oncol. 2009;27:3815–3821. doi:https://doi.org/10.1200/jco.2008.20.5138.
   PubMed Web of Science ®Google Scholar
• Stark GL, Wood KM, Jack F, et al. Hodgkin’s disease in the elderly: a population-based study. Br J Haematol. 2002;119:432–440. doi:https://doi.org/10.1046/j.1365-2141.2002.03815.x.
   PubMed Web of Science ®Google Scholar
• Biccler JL, Glimelius I, Eloranta S, et al. Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: a nordic lymphoma epidemiology group study. J Clin Oncol. 2019;37:703–713. doi:https://doi.org/10.1200/jco.18.01652.
   PubMed Web of Science ®Google Scholar